Cargando…
Control of lupus nephritis by changes of gut microbiota
BACKGROUND: Systemic lupus erythematosus, characterized by persistent inflammation, is a complex autoimmune disorder with no known cure. Immunosuppressants used in treatment put patients at a higher risk of infections. New knowledge of disease modulators, such as symbiotic bacteria, can enable fine-...
Autores principales: | Mu, Qinghui, Zhang, Husen, Liao, Xiaofeng, Lin, Kaisen, Liu, Hualan, Edwards, Michael R., Ahmed, S. Ansar, Yuan, Ruoxi, Li, Liwu, Cecere, Thomas E., Branson, David B., Kirby, Jay L., Goswami, Poorna, Leeth, Caroline M., Read, Kaitlin A., Oestreich, Kenneth J., Vieson, Miranda D., Reilly, Christopher M., Luo, Xin M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505136/ https://www.ncbi.nlm.nih.gov/pubmed/28697806 http://dx.doi.org/10.1186/s40168-017-0300-8 |
Ejemplares similares
-
Antibiotics ameliorate lupus-like symptoms in mice
por: Mu, Qinghui, et al.
Publicado: (2017) -
MicroRNAs Implicated in the Immunopathogenesis of Lupus Nephritis
por: Chafin, Cristen B., et al.
Publicado: (2013) -
Chemokines and Chemokine Receptors in the Development of Lupus Nephritis
por: Liao, Xiaofeng, et al.
Publicado: (2016) -
The Pathogenesis of Lupus Nephritis
por: Sterner, Rosalie M., et al.
Publicado: (2014) -
Hypovitaminosis A Drives the Progression of Tubulointerstitial Lupus Nephritis through Potentiating Predisease Cellular Autoreactivity
por: Abdelhamid, Leila, et al.
Publicado: (2023)